This spotlight session will take a clear, evidence-based look at current scientific evidence, public health assessments, and regulatory debates around reduced-risk nicotine products. Experts will explore how harm reduction is assessed, where scientific consensus exists, where uncertainties exist, and how these findings translate into real-world impacts on adult smokers, consumers, and policy discussions.
Datum
-
Session